ADC Therapeutics operates as a lean, specialized biotechnology enterprise with a global workforce numbering approximately 190 to 200 professional employees. This personnel base is strategically distributed across its primary research and corporate headquarters in Switzerland and its operational branch in New Jersey, United States, comprising clinical researchers, regulatory specialists, commercial teams, and administrative personnel managing its oncology drug portfolio.